设研院(300732) - 2025 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2025 was ¥316,270,886, representing a decrease of 8.12% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥29,644,510.32, a decline of 51.30% year-on-year, while the year-to-date net profit was -¥54,889,630.14, reflecting a 63.01% decrease[4]. - The basic earnings per share for Q3 2025 was -¥0.09, down 52.63% from the previous year, and the diluted earnings per share was also -¥0.09[4]. - The net profit for the current period was a loss of ¥59,412,312.19, an improvement from a loss of ¥148,897,683.55 in the previous period[20]. - The basic and diluted earnings per share were both -¥0.17, an improvement from -¥0.46 in the previous period[21]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,556,778,981.08, an increase of 0.75% from the end of the previous year[4]. - The total assets increased to ¥6,556,778,981.08 from ¥6,507,741,073.54, marking a growth of 0.8%[19]. - Total liabilities decreased to ¥3,586,983,833.95 from ¥3,832,864,501.89, a reduction of 6.4%[19]. - The company experienced a 206.83% increase in current liabilities due to an increase in bank loans due within one year[8]. Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥17,830,040.89, but this was an improvement of 89.50% compared to the same period last year[4]. - Cash inflows from operating activities totaled ¥1,108,710,986.46, down from ¥1,192,317,362.62, a decline of 7.0%[22]. - The net cash flow from operating activities was -$17.83 million, an improvement from -$169.78 million in the previous period[23]. - The company reported a total cash outflow from operating activities of $1.13 billion, down from $1.36 billion last year[23]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 30,826[11]. - The largest shareholder, Henan Jiaoyuan Investment Holding Co., Ltd., holds 29.24% of shares, totaling 108,336,197 shares[11]. - The company has no preferred shareholders or significant changes in restricted shares during the reporting period[13]. Research and Development - Research and development expenses decreased by 33.00% to ¥48,682,232.94, attributed to adjustments in R&D progress[9]. - Research and development expenses were ¥48,682,232.94, a decrease from ¥72,664,986.37, reflecting a reduction of 33.0%[20]. Cash and Equivalents - The total amount of cash and cash equivalents at the end of the period is 675,460,216.57 RMB, down from 691,955,512.09 RMB[17]. - The ending cash and cash equivalents balance was $580.08 million, a decrease from $660.74 million at the beginning of the period[23]. Other Financial Metrics - The company reported a significant increase in the fair value gains from financial assets, amounting to ¥1,067,626.04, compared to a loss of -¥5,537,530.30 in the previous year[9]. - The capital reserve increased by 38.89% to ¥1,322,212,617.13, primarily due to the conversion and redemption of convertible bonds[9]. - Accounts receivable decreased to 1,699,801,487.15 RMB from 1,850,015,561.37 RMB, reflecting a decline of approximately 8.1%[17]. - Inventory increased to 760,028,347.11 RMB from 694,187,434.73 RMB, representing a growth of about 9.5%[17]. - The total non-current assets are valued at 1,370,000,000 RMB, with a slight decrease from the previous period[17]. - The company reported a significant decrease in credit impairment losses, amounting to -¥124,593,211.90 compared to -¥103,596,296.79 in the previous period[20]. Audit and Compliance - The third quarter financial report was not audited[24]. - The company did not execute any new accounting standards in the current reporting period[24].